Abstract:The epigenetic memory stored in the dynamic modifications, such as base modifications of cytosine (C) in DNA, including methylation/hydroxymethylation/demethylation, causes heritable phenotypes via regulating gene expression without alteration of DNA sequence. The process from cytosine modification to the epigenetic effect is orchestrated by complicated machinery consisting of writers, erasers, readers, and other factors. The two major forms of cytosine modification include methylcytosine (5-mC) and hydroxymethylcytosine (5-hmC). DNA methyltransferases (DNMTs) including DNMT1, DNMT3A, and DNMT3B function as writers for 5-mC. The ten-eleven translocation proteins (TET) including TET1, TET2, and TET3 in the mammalian genome are responsible for hydroxymethylation of 5-mC to generate 5-hmC, 5-formylcytosine (5-fC), and 5-carboxylcytosine (5-caC). The 5-mC and 5-hmC have become the two most extensively investigated epigenetic markers, and the dynamic balance of these two markers shape the landscape of the epigenome, functioning as a platform to regulate gene expression epigenetically. The landscape of the 5-hmC in epigenome is precisely and tightly regulated during the development. Aberrant alterations of the epigenetic regulation may cause severe consequences such as phenotype change as well as initiation of disease. Progressively, significant achievements have been made in characterization of writers, erasers, and readers of 5-mC and 5-hmC, as well as the contribution of aberrant alteration of 5-hmC/5-mC landscape to the pathogenesis of human diseases, such as cancers and neurological disorders. This article will highlight the research advances in the distinct contribution of TET proteins as suppressors or promoters to the pathogenesis of tumorigenesis and progression. Furthermore, this article also discusses the challenges and the directions for research in the future.

A Novel Function of TET2 in CNS: Sustaining Neuronal Survival

Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX

Genome-wide Analysis Reveals TET-and TDG-mediated 5-Methylcytosine Oxidation Dynamics

Ten-eleven Translocation 2 Interacts with Forkhead Box O3 and Regulates Adult Neurogenesis

Tet1-mediated DNA Demethylation Regulates Neuronal Cell Death Induced by Oxidative Stress

Tet1 Regulates Adult Hippocampal Neurogenesis and Cognition

Tet2 Activity is Modulated by Sirt1-Mediated Protein Deacetylation: A Potential Therapeutic Target in Myelodysplastic Syndrome

Dynamics of Ten-Eleven Translocation Hydroxylase Family Proteins and 5-Hydroxymethylcytosine in Oligodendrocyte Differentiation

The emerging insights into catalytic or non-catalytic roles of TET proteins in tumors and neural development

Role of TET2 in hematopoietic diseases

TET3 is a positive regulator of mitochondrial respiration in Neuro2A cells

Ten-eleven Translocation 1 Mediated-Dna Hydroxymethylation is Required for Myelination and Remyelination in the Mouse Brain

A Novel Epigenetic Marker, Ten-eleven Translocation Family Member 2 (TET2), is Identified in the Intractable Epileptic Brain and Regulates ATP Binding Cassette Subfamily B Member 1 (ABCB1) in the Blood–brain Barrier

TET (Ten-eleven translocation) family proteins: structure, biological functions and applications

Ten-eleven translocation proteins (TETs): tumor suppressors or tumor enhancers?

The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases

TET1-mediated Oligodendrocyte Homeostasis Regulates Myelination and Synaptic Functions

TET2-mediated Cdkn2A DNA Hydroxymethylation in Midbrain Dopaminergic Neuron Injury of Parkinson's Disease

TET2 chemically modifies tRNAs and regulates tRNA fragment levels

A Primary Role Of Tet Proteins In Establishment And Maintenance Of De Novo Bivalency At Cpg Islands

TET2 plays an essential role in erythropoiesis by regulating lineage-specific genes via DNA oxidative demethylation in a zebrafish model.